Introduction
Tolosa-Hunt Syndrome is a rare, unexplained granulomatous inflammatory condition that primarily affects the cavernous sinus and orbital apex. Its symptoms typically include one-sided head pain, pain behind the eye, and problems with eye movement due to involvement of the oculomotor (III), trochlear (IV), and abducens (VI) cranial nerves.1 With an estimated incidence of one to two cases per million, the condition is extremely uncommon and primarily affects adults, with a mean age of onset of approximately 44 years.2
Neurological rehabilitation plays a critical role in the recovery of patients with Tolosa-Hunt Syndrome, aiming to address the complex issues brought on by the syndrome's neurological deficits. This article highlights effective neurological techniques which focus on pain management, functional recovery and the improvement of patients' overall quality of life.
Understanding tolosa-hunt syndrome
Pathophysiology
Tolosa-Hunt syndrome (THS) is caused by nonspecific inflammation, which usually shows up as one-sided head pain, painful eye movement (ophthalmoplegia) and sensory deficiencies in the oculomotor (III), trochlear (IV), and abducens (VI) nerves as well as in the ophthalmic division of the trigeminal (V) nerve.1,3 Although the precise aetiology is still largely unclear, the inflammation is indicative of an autoimmune condition.4,5 Infiltration of lymphocytes and plasma cells, which fuel the inflammatory response, is frequently seen in histopathological findings.6 THS differs from other causes of cavernous sinus syndrome in that it is primarily idiopathic and responds well to corticosteroid treatment.7
Causes and risk factors
THS is commonly considered an exclusionary diagnosis, made only after other potential causes of cavernous sinus inflammation, such as infections or tumours, have been ruled out, even though its aetiology and risk factors are unknown.5,8 The syndrome has been associated with a number of autoimmune disorders, but it is unclear whether these are coexisting conditions or atypical symptoms of THS itself. Also, the absence of aquaporin-4 (AQP4) antibodies in THS suggests that the condition is not directly associated with neuromyelitis optica (a rare autoimmune disorder in which the immune system mistakenly attacks the optic nerves and spinal cord). This further complicates our understanding of the pathophysiology of THS.8,9
Diagnosis
Clinical presentation and imaging tests, particularly magnetic resonance imaging (MRI), are used to diagnose THS. MRI scans of THS cases typically reveal distinctive soft tissue thickening in the cavernous sinus and surrounding regions.10 The affected tissues are usually enhanced in MRI results, and this can help distinguish THS from other conditions like tumours or vascular malformations.10,11 Another crucial diagnostic factor is the patient's response to corticosteroids, also known as glucocorticoids. The diagnosis of THS is usually confirmed when there is a quick alleviation of symptoms after treatment with steroids.7
Medical treatment and stabilisation
Corticosteroids are the main treatment for THS. These high-dose glucocorticoids are the first-line treatment because of their rapid effectiveness in reducing pain and inflammation, often leading to a noticeable improvement within one to three days of initiation.12 Nonsteroidal anti-inflammatory drugs (NSAIDs) can also be used to treat pain.3 Immunosuppressants like methotrexate or azathioprine are another alternative, primarily for people with steroid dependence, biopsy-proven diagnoses, or repeated flare-ups that are difficult to manage with steroids.13,14
Monitoring is essential because approximately 50% of patients relapse, presenting as ipsilateral, contralateral, or even bilateral cranial nerve palsies.15 To reduce the chances of recurrence while at the same time managing symptom control, cautious and gradual tapering of corticosteroids is required.16 Frequent check-ups and imaging studies can help determine the condition of the cavernous sinus and direct future care.17
Neurological rehabilitation strategies
Neurological rehabilitation is a process that helps people with diseases, injuries, or disorders of the nervous system to improve function, reduce symptoms, and improve quality of life after experiencing a neurological problem. The goals of neurological rehabilitation for Tolosa-Hunt Syndrome are pain management, eye movement improvement, functional ability restoration, and resolving any lingering deficits.
Managing THS is very challenging, and it calls for a multidisciplinary team that includes physiotherapists, psychologists, occupational therapists, and neurologists.9 Below are some important neurological rehabilitation strategies for patients recovering from THS:
- Physical rehabilitation
Patients recovering from THS, especially those with ophthalmoplegia, require physical rehabilitation techniques. Eye movement exercises can be used to improve ocular mobility as they have a potential role in the treatment of idiopathic cranial nerve palsies.18
Posture might also be affected by the neurological impairments linked to THS; thus, strengthening activities for the head and neck muscles are essential for maintaining proper posture. Training in coordination and balance can also be required, especially if patients' conditions cause them to become unstable. Reduced strength, paralysis, or ataxia after neurological impairments can cause difficulties in balance and coordination; thus, physical therapists play an essential role in helping patients recover with customised exercises.19 In addition to enhancing physical function, these physical rehabilitation techniques also help individuals recovering from THS live better lives overall.
- Vision therapy
Vision therapy is another important aspect of neurological rehabilitation for patients suffering from THS. A very common symptom of THS is diplopia (double vision). Diplopia can be treated with corrective lenses to help increase comfort and visual clarity.20 Eye patches or prism glasses may be suggested in situations where alignment problems continue in order to realign visual pathways and lessen double vision.21 Since vision impairments can have a major impact on everyday activities and general well-being, these therapies are especially crucial.
- Pain management
Cranial nerve involvement and inflammation frequently cause severe discomfort, and for such reason, effective pain management as a strategy is essential for THS sufferers. Corticosteroids are the main treatment for THS since they have been demonstrated to quickly reduce pain and other syndrome-related symptoms.15
Adjunctive therapies like acupuncture and biofeedback may help reduce pain and enhance general health in addition to pharmaceutical interventions. It has been observed that acupuncture has the tendency to lessen the frequency and severity of headaches, which is especially beneficial for THS patients who experience persistent headaches.22
Mindfulness and guided imagery are examples of relaxation techniques that can help patients manage their pain and improve their coping strategies.23 In order to avoid symptoms from getting worse while performing regular tasks, physical therapists can also instruct patients on proper posture and ergonomics.
- Psychosocial support
Psychosocial care is another important thing that patients recovering from THS require, as the illness can cause severe emotional discomfort, such as sadness and anxiety. Mental health counselling is very much needed to be incorporated into the neurological rehabilitation procedure in order to address severe emotional discomforts and offer coping mechanisms.
Recovery mostly depends on social interaction and emotional support, which can be facilitated by group therapy or support groups. Patients may feel less alone and more capable of handling their illness if they interact with others going through comparable difficulties.
Monitoring and long-term care
Continuous monitoring and long-term care are a must, as they help in residual symptoms management, recurrence prevention, and help guarantee the best possible recovery. Below are some monitoring and long-term care in THS management:
- Frequent neurological examinations
Since symptoms can differ greatly from patient to patient, routine neurological evaluations are essential for tracking the course of THS. Frequent evaluations are needed to determine treatment efficacy and the likelihood of recurrence, as the syndrome usually manifests as hemi-cranial pain, retro-orbital pain, and oculomotor nerve paralysis.1
- Medications and therapy adjustments based on the patient’s progress towards recovery
Given the high response rate to corticosteroids, which act as a therapeutic and diagnostic tool, medication and therapy must be adjusted in response to patient progress.15 Recurrence is actually quite common, as reports suggest that after initial treatment, up to 50% of patients tend to develop ipsilateral, contralateral, or even bilateral cranial nerve paralysis.15 To maximise patient outcomes and reduce the risk of complications, clinicians must be vigilant in adjusting treatment regimens.
Another crucial component of long-term care is managing the side effects of steroids. Despite their effectiveness, corticosteroids can cause several unwanted side effects, such as weight gain, hypertension, and an increased risk of infection.24 Healthcare professionals must educate patients on the possible side effects of corticosteroids and keep a careful eye on them during the course of treatment. To lessen the negative effects of long-term steroid use, this involves routine evaluations of blood pressure, glucose levels, and general health status.25
- Patient education on stress management, lifestyle changes, and self-care
An important part of managing THS has to do with educating patients about lifestyle changes and self-care. Patients should be made aware of the significance of strictly following treatment plans, identifying recurrence symptoms, and making lifestyle adjustments that could improve their general health. These include but are not limited to dietary changes, stress reduction strategies, and regular exercise, all of which can enhance patients’ overall health and quality of life.26
Also, being aware of the nature of their illness encourages patients to actively participate in their treatment, which strengthens their bond with their medical professionals.27
Summary
For patients with Tolosa-Hunt syndrome, neurological rehabilitation is crucial to maximising recovery. Long-term rehabilitation is essential to manage residual impairments, avoid relapses, and enhance quality of life, even though corticosteroids offer quick symptom relief. Neurological rehabilitation strategies for patients recovering from the condition include pain management, vision therapy for diplopia, physical therapy for eye movement restoration and psychosocial support.
Regular neurological evaluations, medication adjustments, and patient education regarding lifestyle changes are also required due to the risk of recurrence. To improve patient outcomes, future studies should investigate novel treatments and improve neurological rehabilitation techniques. An organised, patient-focused strategy guarantees improved functionality and long-term health.
References
- Peddi P, Gallagher KM, Chandrasekharan C, Wang Q, Gonzalez-Toledo E, Nair BS, et al. Tolosa-Hunt syndrome in double-hit lymphoma. Case Rep Oncol Med [Internet]. 2015 [cited 2025 Jan 30];2015:1–4. Available from: https://pubmed.ncbi.nlm.nih.gov/25918657/
- Corredor MM, Holmberg PJ. Ophthalmoplegia and cranial nerve deficits in an adolescent with headache. SAGE Open Med Case Rep [Internet]. 2021 [cited 2025 Jan 30];9. Available from: https://pubmed.ncbi.nlm.nih.gov/34178348/
- Arthur A, Sivadasan A, Mannam P, Prabakhar A, Aaron S, Mathew V, et al. Tolosa–Hunt Syndrome: Long-Term Outcome and Role of Steroid-Sparing Agents. Ann Indian Acad Neurol [Internet]. 2020 Mar 1 [cited 2025 Feb 1];23(2):201. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7061504/
- Filho ARG, Faccenda PG, Estacia CT, Correa BS, Curi I. Tolosa-Hunt Syndrome. Rev Bras Oftalmol [Internet]. 2023 Aug 8 [cited 2025 Feb 1];77(5):289–91. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459225/
- Arshad A, Nabi S, Panhwar MS, Rahil A. Tolosa-Hunt syndrome: An arcane pathology of cavernous venous sinus. BMJ Case Rep. 2015 Aug 20;2015.
- Bowman S, Helming A. Complete ophthalmoplegia diagnosed as Tolosa-Hunt syndrome on interval MRI. BMJ Case Rep [Internet]. 2022 Nov 3 [cited 2025 Feb 1];15(11). Available from: https://pubmed.ncbi.nlm.nih.gov/36328364/
- Yu S, Chen T. Pearls & Oy-sters: Idiopathic Orbital Inflammation and Tolosa-Hunt Syndrome With Intracranial Extension. Neurology [Internet]. 2023 Aug 22 [cited 2025 Jan 30];101(8):371. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10449447/
- Park SH, Jang SI, Lee EJ, Kim NH. Case report: Tolosa-Hunt syndrome—expanding the neuromyelitis optica spectrum disorder phenotype? Front Neurol. 2024;15.
- Naoual M, Hind H, Roukaya C, Ghizlane D, Loubna EM, Bouchra A, et al. Ptosis Revealing A Tolosa Hunt Syndrome: A Case Report. European Journal of Medical and Health Sciences. 2023 Jul 13;5(4):1–2.
- Abdelrahman A, Elgassim M, Abdalkarim A, Babiker AM, Abdeen M, Abass SM, et al. Case Report: Tolosa-Hunt syndrome, a neuroinflammatory origin of painful ophthalmoplegia. F1000Research 2023 12:1594 [Internet]. 2023 Dec 14 [cited 2025 Feb 1];12:1594. Available from: https://f1000research.com/articles/12-1594
- Yang Q, Lai C, Meng C, Chang Q, Wang J. Clinical and Cerebrospinal Fluid Characteristics in 55 Cases of Tolosa-Hunt Syndrome: A Retrospective Analytical Study. Eur Neurol [Internet]. 2022 Aug 2 [cited 2025 Feb 1];85(4):265–72. Available from: https://dx.doi.org/10.1159/000522187
- Siddhanta KC, Shreeyanta KC, Kunwar P, Dhungana K. Tolosa-Hunt Syndrome: A Case Report. JNMA J Nepal Med Assoc [Internet]. 2021 Jun 1 [cited 2025 Feb 1];59(238):604–7. Available from: https://pubmed.ncbi.nlm.nih.gov/34508416/
- Kumar S. Ophthalmoplegia syndrome or tolosa hunt syndrome – A review. IP International Journal of Ocular Oncology and Oculoplasty. 2024 Feb 28;9(4):166–9.
- Wiener J, Cron RQ. Successful treatment of pediatric Tolosa-Hunt syndrome with adalimumab. Eur J Rheumatol [Internet]. 2019 Feb 3 [cited 2025 Feb 1];7(Suppl 1):S82. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7004262/
- T M Kesavan A, Premanandan S, Basith AN. Tolosa-Hunt syndrome – A case of treatable headache. IP International Journal of Medical Paediatrics and Oncology. 2021 Oct 28;7(3):167–9.
- Rotstein DL, Tyndel FJ, Tang-Wai DF. A case report of cavernous sinus syndrome in a patient with Takayasu’s arteritis. Headache [Internet]. 2014 Sep 1 [cited 2025 Feb 1];54(8):1371–5. Available from: https://pubmed.ncbi.nlm.nih.gov/24827146/
- Pérez CA, Evangelista M. Evaluation and Management of Tolosa–Hunt Syndrome in Children: A Clinical Update. Vol. 62, Pediatric Neurology. Elsevier Inc.; 2016. p. 18–26.
- Rodriguez SL, Hopman WM, Ten Hove MW. Eye exercises for treatment of idiopathic cranial nerve VII paresis: pilot study. Can J Neurol Sci [Internet]. 2012 Mar 1 [cited 2025 Feb 1];39(2):196–201. Available from: https://pubmed.ncbi.nlm.nih.gov/22343153/
- Li J, Zhong D, Ye J, He M, Liu X, Zheng H, et al. Rehabilitation for balance impairment in patients after stroke: A protocol of a systematic review and network meta-analysis. BMJ Open. 2019 Jul 1;9(7).
- Alemu HW, Kumar P. Monocular Diplopia: An Optical Correction Modality. Case Rep Ophthalmol [Internet]. 2021 Jun 11 [cited 2025 Feb 1];12(2):501. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8255654/
- Braaksma-Besselink Y, Jellema HM. Diplopia. Surgery in and around the Orbit: CrossRoads [Internet]. 2024 Feb 29 [cited 2025 Feb 1];149–68. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441905/
- Kolokotsios S, Stamouli A, Koukoulithras I, Plexousakis M, Drousia G. The Effectiveness of Acupuncture on Headache Intensity and Frequency in Patients With Tension-Type Headache: A Systematic Review and Meta-Analysis. Cureus [Internet]. 2021 Apr 1 [cited 2025 Feb 1];13(4):e14237. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8087950/
- Vambheim SM, Kyllo TM, Hegland S, Bystad M. Relaxation techniques as an intervention for chronic pain: A systematic review of randomized controlled trials. Heliyon [Internet]. 2021 Aug 1 [cited 2025 Feb 1];7(8):e07837. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8405991/
- Yasir M, Goyal A, Sonthalia S. Corticosteroid Adverse Effects. StatPearls [Internet]. 2023 Jul 3 [cited 2025 Feb 1]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK531462/
- Aberer F, Hochfellner DA, Sourij H, Mader JK, Sourij DA;, Mader H;, et al. A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital. J Clin Med [Internet]. 2021 May 2 [cited 2025 Feb 1];10(10):2154. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8157052/
- Danielson E, Melin-Johansso C, Modanloo M. Adherence to Treatment in Patients with Chronic Diseases: From Alertness to Persistence. Int J Community Based Nurs Midwifery [Internet]. 2019 [cited 2025 Feb 1];7(4):248. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6779922/
- Pagès-Puigdemont N, Mangues MA, Masip M, Gabriele G, Fernández-Maldonado L, Blancafort S, et al. Patients’ Perspective of Medication Adherence in Chronic Conditions: A Qualitative Study. Adv Ther [Internet]. 2016 Oct 1 [cited 2025 Feb 1];33(10):1740–54. Available from: https://link.springer.com/article/10.1007/s12325-016-0394-6

